SchwabS.J., BullerG.L., McCannR.L., BollingerR.R., StickelD.L.Prospective evaluation of a Dacron cuffed hemodialysis catheter for prolonged use. Am J Kidney Dis1988; 2: 166–9.
2.
MossA.H., VasilakisC., HolleyJ.L., FoulksC.J., PillaiK., McDowellD.E.Use of silicone dual-lumen catheter with a Dacron cuff as a long-term vascular access for hemodialysis patients. Am J Kidney Dis1990; 16: 211–5.
DaeihaghP., JordanJ., ChenJ., RoccoM.Efficacy of tissue plasminogen activator administration on patency of hemodialysis access catheters. Am J Kidney Dis102000; 36: 75–79.
9.
DavisS.N., VermeulenL., BantonJ., SchwartzB.S., WilliamsE.C.Activity and dosage of alteplase dilution for clearing occlusions of venous-access devices. Am J Health Syst Pharm102000; 57: 1039–45.
10.
HaireW.D., AtkinsonJ.B., StephensL.C., KotulakG.D.Urokinase versus recombinant tissue plasminogen activator in thrombosed central venous catheters: a double-blinded, randomized trial. Thromb Haemost1994; 72: 543–7.
11.
AtkinsonJ.B., BagnallH.A., GompertsE.Investigational use of tissue plasminogen activator (t-PA) for occluded central venous catheters. JPEN1990; 14: 310–1.
